SPRUCE BIOSCIENCES INC (SPRB) — insider trading
Health Care · NASDAQ
SPRUCE BIOSCIENCES INC (SPRB) has 30 reported SEC Form 4 insider transactions in our data (latest 2026-07-27).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-27 | Quartel Adrian W | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 13,000 | — | $0 | Form 4 |
| 2026-06-30 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant / award / vesting | 266 | $4.53 | $1.2K | Form 4 |
| 2026-05-21 | Walbert Keli | Director | Grant / award / vesting (derivative) | 1,700 | — | $0 | Form 4 |
| 2026-05-21 | Barretto-Ko Percival | Director | Grant / award / vesting (derivative) | 1,700 | — | $0 | Form 4 |
| 2026-05-21 | GREY MICHAEL G | Director, Officer (Executive Chairman) | Grant / award / vesting (derivative) | 1,700 | — | $0 | Form 4 |
| 2026-05-21 | SIMPSON CAMILLA V | Director | Grant / award / vesting (derivative) | 1,700 | — | $0 | Form 4 |
| 2026-05-21 | SPIEGELMAN DANIEL K | Director | Grant / award / vesting (derivative) | 1,700 | — | $0 | Form 4 |
| 2026-03-09 | Hooks Corwin Dale | Officer (Chief Commercial Officer) | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2025-12-31 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant / award / vesting | 4,690 | $4.53 | $21.2K | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise / conversion (derivative) | 1,196 | — | $0 | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise / conversion (derivative) | 1,480 | — | $0 | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 608 | $80.67 | $49.0K | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise / conversion | 1,196 | — | $0 | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 752 | $80.67 | $60.7K | Form 4 |
| 2025-12-15 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise / conversion | 1,480 | — | $0 | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Option exercise / conversion (derivative) | 513 | — | $0 | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Option exercise / conversion (derivative) | 496 | — | $0 | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Shares withheld for taxes / exercise cost | 184 | $80.67 | $14.8K | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Option exercise / conversion | 513 | — | $0 | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Shares withheld for taxes / exercise cost | 178 | $80.67 | $14.4K | Form 4 |
| 2025-12-15 | Gharib Samir M. | Officer (PRESIDENT AND CFO) | Option exercise / conversion | 496 | — | $0 | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Disposition to the issuer (derivative) | 400 | — | — | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Grant / award / vesting (derivative) | 400 | — | — | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Disposition to the issuer (derivative) | 266 | — | — | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Grant / award / vesting (derivative) | 266 | — | — | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Option exercise / conversion (derivative) | 1,250 | — | $0 | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Grant / award / vesting (derivative) | 5,000 | — | $0 | Form 4 |
| 2025-12-11 | Ways Douglas Kirk | Director, Officer (Interim Chief Medical Officer) | Option exercise / conversion | 1,250 | — | $0 | Form 4 |
| 2025-12-11 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Disposition to the issuer (derivative) | 1,666 | — | — | Form 4 |
| 2025-12-11 | Szwarcberg Javier B. | Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant / award / vesting (derivative) | 1,666 | — | — | Form 4 |
Ask the chat about SPRB's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SPRUCE BIOSCIENCES INC (SPRB).
Last updated 2026-07-27 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.